| Role of quinones in toxicology JL Bolton, MA Trush, TM Penning, G Dryhurst, TJ Monks Chemical research in toxicology 13 (3), 135-160, 2000 | 2060 | 2000 |
| Quinone chemistry and toxicity TJ Monks, RP Hanzlik, GM Cohen, D Ross, DG Graham Toxicology and applied pharmacology 112 (1), 2-16, 1992 | 981 | 1992 |
| The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers TJ Monks, DC Jones Current drug metabolism 3 (4), 425-438, 2002 | 379 | 2002 |
| Glutathione conjugate mediated toxicities TJ Monks, MW Anders, W Dekant, JL Stevens, SS Lau, PJ van Bladeren Toxicology and applied pharmacology 106 (1), 1-19, 1990 | 319 | 1990 |
| Sequential oxidation and glutathione addition to 1, 4-benzoquinone: correlation of toxicity with increased glutathione substitution. SS Lau, BA Hill, RJ Highet, TJ Monks Molecular pharmacology 34 (6), 769-778, 1988 | 230 | 1988 |
| Acetaminophen-induced hepatotoxicity JA Hinson, LR Pohl, TJ Monks, JR Gillette Life sciences 29 (2), 107-116, 1981 | 224 | 1981 |
| Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. TJ Monks, SS Lau, RJ Highet, JR Gillette Drug Metabolism and Disposition 13 (5), 553-559, 1985 | 195 | 1985 |
| Evidence for DNA damage in amyotrophic lateral sclerosis. PS Fitzmaurice, IC Shaw, HE Kleiner, RT Miller, TJ Monks, SS Lau, ... Muscle & nerve 19 (6), 797-798, 1996 | 165 | 1996 |
| Toxicology of quinone-thioethers TJ Monks, SS Lau Critical reviews in toxicology 22 (5-6), 243-270, 1992 | 165 | 1992 |
| The Cytoprotective Effect of N-acetyl-L-cysteine against ROS-Induced Cytotoxicity Is Independent of Its Ability to Enhance Glutathione Synthesis F Zhang, SS Lau, TJ Monks Toxicological sciences 120 (1), 87-97, 2011 | 162 | 2011 |
| Biological reactivity of polyphenolic− glutathione conjugates TJ Monks, SS Lau Chemical research in toxicology 10 (12), 1296-1313, 1997 | 162 | 1997 |
| 3-(glutathion-S-yl) acetaminophen: a biliary metabolite of acetaminophen. JA Hinson, TJ Monks, M Hong, RJ Highet, LR Pohl Drug Metabolism and Disposition 10 (1), 47-50, 1982 | 159 | 1982 |
| The role of metabolism in 3, 4-(±)-methylenedioxyamphetamine and 3, 4-(±)-methylenedioxymethamphetamine (Ecstasy) toxicity TJ Monks, DC Jones, F Bai, SS Lau Therapeutic drug monitoring 26 (2), 132-136, 2004 | 149 | 2004 |
| Glutathione and N-Acetylcysteine Conjugates of α-Methyldopamine Produce Serotonergic Neurotoxicity: Possible Role in Methylenedioxyamphetamine-Mediated … F Bai, SS Lau, TJ Monks Chemical research in toxicology 12 (12), 1150-1157, 1999 | 147 | 1999 |
| The formation of diglutathionyl dithiocarbonate as a metabolite of chloroform, bromotrichloromethane, and carbon tetrachloride. LR Pohl, RV Branchflower, RJ Highet, JL Martin, DS Nunn, TJ Monks, ... Drug Metabolism and Disposition 9 (4), 334-339, 1981 | 141 | 1981 |
| Serotonergic neurotoxic metabolites of ecstasy identified in rat brain DC Jones, C Duvauchelle, A Ikegami, CM Olsen, SS Lau, R de la Torre, ... Journal of Pharmacology and Experimental Therapeutics 313 (1), 422-431, 2005 | 134 | 2005 |
| EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death J Dong, S Ramachandiran, K Tikoo, Z Jia, SS Lau, TJ Monks American Journal of Physiology-Renal Physiology 287 (5), F1049-F1058, 2004 | 129 | 2004 |
| Reactive intermediates and their toxicological significance TJ Monks, SS Lau Toxicology 52 (1-2), 1-53, 1988 | 128 | 1988 |
| The pharmacology and toxicology of polyphenolic-glutathione conjugates TJ Monks, SS Lau Annual review of pharmacology and toxicology 38 (1), 229-255, 1998 | 127 | 1998 |
| 2, 5-Bis-(glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3, 4-methylenedioxyamphetamine, decreases brain serotonin concentrations RT Miller, SS Lau, TJ Monks European journal of pharmacology 323 (2-3), 173-180, 1997 | 124 | 1997 |
